In Vitro Fertilization Services Market - 2025-2033
Description
IN VITRO FERTILIZATION (IVF) SERVICES MARKET OVERVIEW
In Vitro Fertilization (IVF) Services Market reached US$ 24.91 Billion in 2024 and is expected to reach US$ 52.50 Billion by 2033, growing at a CAGR of 8.6 % during the forecast period 2025-2033, according to DataM Intelligence report.
In vitro fertilization (IVF (https://www.datamintelligence.com/research-report/in-vitro-fertilization-market)) services are a medical procedure that facilitates fertilization by combining an egg with sperm outside the body, typically in a laboratory environment. The term ""in vitro,"" which translates to ""in glass,"" signifies that the fertilization process occurs in a controlled setting rather than within the human body. The IVF process generally consists of several key steps, including ovarian stimulation, egg retrieval, fertilization, embryo culture, and embryo transfer.
IVF services are commonly employed to address various causes of infertility, including advanced maternal age, blocked fallopian tubes, male factor infertility, endometriosis, and unexplained infertility. This procedure has become a vital option for many couples seeking to conceive when faced with challenges related to fertility. These factors have expanded the global in vitro fertilization (IVF) services market.
EXECUTIVE SUMMARY
Source- DataM Intelligence
For more details on this report – Request for Sample (https://www.datamintelligence.com/download-sample/in-vitro-fertilization-services-market)
IN VITRO FERTILIZATION (IVF) SERVICES MARKET DYNAMICS: DRIVERS
INCREASING INCIDENCE OF INFERTILITY
This increase in infertility rates can be linked to a range of social, economic, and health-related factors that have developed over recent decades. As per the Cofertility data in October 2024, infertility is a significant global health issue, affecting approximately 1 in 6 individuals worldwide. This statistic highlights the prevalence of infertility as a major concern that transcends geographical and socioeconomic boundaries. About 17.5% of the adult population experiences infertility at some point in their lives.
This translates to roughly 1 in 6 individuals, indicating that infertility is a widespread issue affecting millions globally. Approximately 12% of women encounter difficulties either becoming pregnant or carrying a child to term. 19% of all couples are unable to conceive after one year of unprotected sexual intercourse. Furthermore, 10% of couples remain unable to conceive after two years of unprotected sex, indicating that prolonged infertility is a common experience for many.
The increasing incidence of infertility is directly linked to a heightened demand for IVF services. As more couples seek assistance in conceiving, fertility clinics are experiencing a rise in patient volumes and expanding their range of service offerings. The utilization of assisted reproductive technologies has been growing at an annual rate of 5% to 10%, reflecting a growing reliance on IVF as a viable solution for infertility. This trend is further bolstered by advancements in reproductive technology that enhance success rates and make treatments more effective.
IN VITRO FERTILIZATION (IVF) SERVICES MARKET DYNAMICS: RESTRAINTS
HIGH COSTS OF IVF PROCEDURES
The high costs of IVF procedures will hinder the growth of the global in vitro fertilization (IVF) services market. The global in vitro fertilization (IVF) services market is significantly impacted by various restraints that hinder its growth and accessibility. Among these, high treatment costs, financial burdens, and ethical considerations are paramount.
Many patients find that they require multiple IVF cycles to achieve a successful pregnancy. Research indicates that the average patient undergoes approximately 2.3 to 2.7 cycles, leading to cumulative expenses that can exceed $50,000 over time. Each additional cycle incurs an average cost of around $6,955, further compounding the financial strain on couples. The cost of IVF can vary significantly based on geographic location. For instance, clinics in major metropolitan areas may charge higher rates compared to those in rural settings. Thus, the above factors could be limiting the global in vitro fertilization (IVF) services market's potential growth.
IN VITRO FERTILIZATION (IVF) SERVICES MARKET SEGMENT ANALYSIS
The global in vitro fertilization (IVF) services market is segmented based on treatment type, end-user, and region.
TREATMENT TYPE:
THE CONVENTIONAL IVF TREATMENT TYPE SEGMENT IS EXPECTED TO HOLD 34.6% OF THE GLOBAL IN VITRO FERTILIZATION (IVF) SERVICES MARKET IN 2024
Conventional IVF (c-IVF) remains one of the most widely practiced assisted reproductive technology (ART) methods globally. However, recent years have seen a significant decline in the number of c-IVF procedures, largely due to the increasing preference for intracytoplasmic sperm injection (ICSI), particularly in cases of non-male-related infertility.
Key advancements in ART include improvements in controlled ovarian hyperstimulation, oocyte retrieval techniques, embryonic culture conditions, and freezing procedures, all of which have significantly enhanced human fertility treatments.
One of the most notable technological innovations in ART is intracytoplasmic sperm injection (ICSI), developed to address the low and unpredictable fertilization rates often encountered with conventional in vitro fertilization (c-IVF), particularly in cases involving poor sperm parameters. However, over the last two decades, there has been a rapid increase in the adoption of ICSI, raising questions about its appropriateness in various clinical situations.
For instance, in December 2024, Gameto (https://finance.yahoo.com/news/gameto-announces-world-first-live-130000229.html)announced the world’s first live birth resulting from its Fertilo procedure, a groundbreaking technology that matures eggs outside the body using engineered ovarian support cells derived from induced pluripotent stem cells (iPSCs).
Traditionally, women undergoing in vitro fertilization (IVF) must take high doses of hormone injections for 10–14 days to mature eggs within their ovaries. Pioneering ovarian support cell technology enables egg maturation outside the body, eliminating nearly 80% of the hormone injections typically needed for conventional in-vitro fertilization (IVF). These factors have solidified the segment's position in the global in vitro fertilization (IVF) services market.
IN VITRO FERTILIZATION (IVF) SERVICES MARKET GEOGRAPHICAL ANALYSIS
NORTH AMERICA IS EXPECTED TO HOLD 45.6% OF THE GLOBAL IN VITRO FERTILIZATION (IVF) SERVICES MARKET IN 2024
As infertility becomes more prevalent, the demand for IVF services continues to rise. Couples facing difficulties in conceiving are increasingly turning to assisted reproductive technologies as viable options. The growing awareness and acceptance of IVF as a solution contribute significantly to market growth.
Infertility has become a significant health issue, affecting approximately 1 in 8 couples in the United States. This statistic highlights the prevalence of infertility, which can result from various factors, including age, lifestyle, and medical conditions. Infertility affects a significant portion of the population, with over 10% of women and around 9% of men experiencing infertility issues in the U.S. This rising prevalence drives demand for IVF services as couples seek effective reproductive solutions.
Continuous improvements in reproductive technologies, including controlled ovarian hyperstimulation and embryo culture techniques, have enhanced the success rates of IVF procedures. Innovations such as intracytoplasmic sperm injection (ICSI) have also contributed to better outcomes, especially in cases of male infertility.
Furthermore, key players in the industry have innovative launches and technological advancements that would drive this in vitro fertilization (IVF) services market growth. For instance, in October 2024, Cook Medical announced the launch of its NestVT vitrification device for In Vitro Fertilization (IVF) in the United States.
This innovative device is designed to enhance the safety and efficiency of handling embryos and oocytes during the critical processes of vitrification, cryo-storage, and relocation. Thus, the above factors are consolidating the region's position as a dominant force in the global in vitro fertilization (IVF) services market.
ASIA-PACIFIC IS EXPECTED TO HOLD 23.4% OF THE GLOBAL IN VITRO FERTILIZATION (IVF) SERVICES MARKET IN 2024
The rise in infertility cases among both men and women is a significant driver for the IVF market. Factors such as sedentary lifestyles, poor dietary habits, and increased exposure to environmental pollutants contribute to this trend. Common conditions likepolycystic ovary syndrome (PCOS) (https://www.datamintelligence.com/research-report/polycystic-ovary-syndrome-market)and endometriosis further exacerbate infertility rates, leading many couples to seek assisted reproductive technologies like IVF.
Rapid advancements in IVF technologies have significantly improved success rates and treatment effectiveness. Innovations such as controlled ovarian hyperstimulation, embryo culture techniques, and intracytoplasmic sperm injection (ICSI) have enhanced overall outcomes for IVF procedures, making them more appealing to couples facing infertility.
Many governments in the region are introducing supportive policies and funding initiatives aimed at promoting reproductive health services, including IVF. This financial backing helps reduce the costs associated with fertility treatments, making them more accessible to a broader population. India has experienced a notable surge in in vitro fertilization (IVF) services, driven by several interrelated factors. This growth reflects changing societal norms, economic conditions, and increasing awareness surrounding fertility treatments.
Furthermore, key players in the industry are introducing innovative technologies and government initiatives that would drive the global in vitro fertilization (IVF) services market growth. For instance, in January 2025, NewGenIvf Group Limited (NASDAQ: NIVF), a leading fertility services provider in Asia, announced the launch of its innovative lifetime egg freezing service.
This new “one charge, no worries” fertility preservation solution allows women across Asia to make a single payment for lifetime egg freezing, addressing the growing demand for accessible and convenient fertility preservation options. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global in vitro fertilization (IVF) services market.
IN VITRO FERTILIZATION (IVF) SERVICES MARKET MAJOR PLAYERS
The major global players in the in vitro fertilization (IVF) services market include Virtus Health, Genea Pty Limited, Aksigen (https://www.aksigenivf.com/ivf-treatment), Shady Grove Fertility, New Hope Fertility Clinic, Boston IVF, Cyprus IVF Centre, EUVITRO S.L.U., Fertility Centers of Illinois, and Houston Fertility Center, among others.
IN VITRO FERTILIZATION (IVF) SERVICES MARKET - KEY DEVELOPMENTS
• In April 2025, The Wyatt Foundation and The Conceive Fertility Foundation are excited to announce the launch of their 2025 IVF Grant Program. This initiative will provide $15,000 grants to five individuals or couples who require in vitro fertilization (IVF) to grow their families.
• In March 2025, TMRW Life Sciences (https://femtechinsider.com/tmrw-life-sciences-launches-tmrw-vault-a-smart-tank-solution-for-ivf-specimen-management/) announced the launch of TMRW Vault, its latest advancement in the management and storage of frozen IVF specimens such as eggs, embryos, and sperm. The TMRW Vault is a state-of-the-art liquid nitrogen smart tank and digital workstation that combines advanced digital specimen management with the convenience and speed of manual storage access.
• In September 2024, MGM Healthcare (http://thehindu.com/news/cities/chennai/mgm-healthcare-launches-dedicated-centre-for-ivf-services/article68648739.ece) launched its Varam IVF Centre in Chennai, which aims to provide comprehensive and advanced fertility treatments. This initiative is designed to cater to couples facing infertility challenges by combining specialized medical expertise with state-of-the-art technology and a range of ancillary services, all within one facility.
MARKET SCOPE
Metrics Details
CAGR 8.6%
Market Size Available for Years 2022-2033
Estimation Forecast Period 2025-2033
Revenue Units Value (US$ Bn)
Segments Covered Treatment Type Conventional IVF, Intracytoplasmic Sperm Injection (ICSI), Mini IVF, Natural Cycle IVF, Fresh Cycle IVF, Frozen Embryo Transfer (FET), Others
End-User Fertility Clinics, Hospitals, Others
Regions Covered North America, Europe, Asia-Pacific, South America, and Middle East & Africa
The global IVF services market report delivers a detailed analysis with 54 key tables, more than 46 visually impactful figures, and 173 pages of expert insights, providing a complete view of the market landscape.
In Vitro Fertilization (IVF) Services Market reached US$ 24.91 Billion in 2024 and is expected to reach US$ 52.50 Billion by 2033, growing at a CAGR of 8.6 % during the forecast period 2025-2033, according to DataM Intelligence report.
In vitro fertilization (IVF (https://www.datamintelligence.com/research-report/in-vitro-fertilization-market)) services are a medical procedure that facilitates fertilization by combining an egg with sperm outside the body, typically in a laboratory environment. The term ""in vitro,"" which translates to ""in glass,"" signifies that the fertilization process occurs in a controlled setting rather than within the human body. The IVF process generally consists of several key steps, including ovarian stimulation, egg retrieval, fertilization, embryo culture, and embryo transfer.
IVF services are commonly employed to address various causes of infertility, including advanced maternal age, blocked fallopian tubes, male factor infertility, endometriosis, and unexplained infertility. This procedure has become a vital option for many couples seeking to conceive when faced with challenges related to fertility. These factors have expanded the global in vitro fertilization (IVF) services market.
EXECUTIVE SUMMARY
Source- DataM Intelligence
For more details on this report – Request for Sample (https://www.datamintelligence.com/download-sample/in-vitro-fertilization-services-market)
IN VITRO FERTILIZATION (IVF) SERVICES MARKET DYNAMICS: DRIVERS
INCREASING INCIDENCE OF INFERTILITY
This increase in infertility rates can be linked to a range of social, economic, and health-related factors that have developed over recent decades. As per the Cofertility data in October 2024, infertility is a significant global health issue, affecting approximately 1 in 6 individuals worldwide. This statistic highlights the prevalence of infertility as a major concern that transcends geographical and socioeconomic boundaries. About 17.5% of the adult population experiences infertility at some point in their lives.
This translates to roughly 1 in 6 individuals, indicating that infertility is a widespread issue affecting millions globally. Approximately 12% of women encounter difficulties either becoming pregnant or carrying a child to term. 19% of all couples are unable to conceive after one year of unprotected sexual intercourse. Furthermore, 10% of couples remain unable to conceive after two years of unprotected sex, indicating that prolonged infertility is a common experience for many.
The increasing incidence of infertility is directly linked to a heightened demand for IVF services. As more couples seek assistance in conceiving, fertility clinics are experiencing a rise in patient volumes and expanding their range of service offerings. The utilization of assisted reproductive technologies has been growing at an annual rate of 5% to 10%, reflecting a growing reliance on IVF as a viable solution for infertility. This trend is further bolstered by advancements in reproductive technology that enhance success rates and make treatments more effective.
IN VITRO FERTILIZATION (IVF) SERVICES MARKET DYNAMICS: RESTRAINTS
HIGH COSTS OF IVF PROCEDURES
The high costs of IVF procedures will hinder the growth of the global in vitro fertilization (IVF) services market. The global in vitro fertilization (IVF) services market is significantly impacted by various restraints that hinder its growth and accessibility. Among these, high treatment costs, financial burdens, and ethical considerations are paramount.
Many patients find that they require multiple IVF cycles to achieve a successful pregnancy. Research indicates that the average patient undergoes approximately 2.3 to 2.7 cycles, leading to cumulative expenses that can exceed $50,000 over time. Each additional cycle incurs an average cost of around $6,955, further compounding the financial strain on couples. The cost of IVF can vary significantly based on geographic location. For instance, clinics in major metropolitan areas may charge higher rates compared to those in rural settings. Thus, the above factors could be limiting the global in vitro fertilization (IVF) services market's potential growth.
IN VITRO FERTILIZATION (IVF) SERVICES MARKET SEGMENT ANALYSIS
The global in vitro fertilization (IVF) services market is segmented based on treatment type, end-user, and region.
TREATMENT TYPE:
THE CONVENTIONAL IVF TREATMENT TYPE SEGMENT IS EXPECTED TO HOLD 34.6% OF THE GLOBAL IN VITRO FERTILIZATION (IVF) SERVICES MARKET IN 2024
Conventional IVF (c-IVF) remains one of the most widely practiced assisted reproductive technology (ART) methods globally. However, recent years have seen a significant decline in the number of c-IVF procedures, largely due to the increasing preference for intracytoplasmic sperm injection (ICSI), particularly in cases of non-male-related infertility.
Key advancements in ART include improvements in controlled ovarian hyperstimulation, oocyte retrieval techniques, embryonic culture conditions, and freezing procedures, all of which have significantly enhanced human fertility treatments.
One of the most notable technological innovations in ART is intracytoplasmic sperm injection (ICSI), developed to address the low and unpredictable fertilization rates often encountered with conventional in vitro fertilization (c-IVF), particularly in cases involving poor sperm parameters. However, over the last two decades, there has been a rapid increase in the adoption of ICSI, raising questions about its appropriateness in various clinical situations.
For instance, in December 2024, Gameto (https://finance.yahoo.com/news/gameto-announces-world-first-live-130000229.html)announced the world’s first live birth resulting from its Fertilo procedure, a groundbreaking technology that matures eggs outside the body using engineered ovarian support cells derived from induced pluripotent stem cells (iPSCs).
Traditionally, women undergoing in vitro fertilization (IVF) must take high doses of hormone injections for 10–14 days to mature eggs within their ovaries. Pioneering ovarian support cell technology enables egg maturation outside the body, eliminating nearly 80% of the hormone injections typically needed for conventional in-vitro fertilization (IVF). These factors have solidified the segment's position in the global in vitro fertilization (IVF) services market.
IN VITRO FERTILIZATION (IVF) SERVICES MARKET GEOGRAPHICAL ANALYSIS
NORTH AMERICA IS EXPECTED TO HOLD 45.6% OF THE GLOBAL IN VITRO FERTILIZATION (IVF) SERVICES MARKET IN 2024
As infertility becomes more prevalent, the demand for IVF services continues to rise. Couples facing difficulties in conceiving are increasingly turning to assisted reproductive technologies as viable options. The growing awareness and acceptance of IVF as a solution contribute significantly to market growth.
Infertility has become a significant health issue, affecting approximately 1 in 8 couples in the United States. This statistic highlights the prevalence of infertility, which can result from various factors, including age, lifestyle, and medical conditions. Infertility affects a significant portion of the population, with over 10% of women and around 9% of men experiencing infertility issues in the U.S. This rising prevalence drives demand for IVF services as couples seek effective reproductive solutions.
Continuous improvements in reproductive technologies, including controlled ovarian hyperstimulation and embryo culture techniques, have enhanced the success rates of IVF procedures. Innovations such as intracytoplasmic sperm injection (ICSI) have also contributed to better outcomes, especially in cases of male infertility.
Furthermore, key players in the industry have innovative launches and technological advancements that would drive this in vitro fertilization (IVF) services market growth. For instance, in October 2024, Cook Medical announced the launch of its NestVT vitrification device for In Vitro Fertilization (IVF) in the United States.
This innovative device is designed to enhance the safety and efficiency of handling embryos and oocytes during the critical processes of vitrification, cryo-storage, and relocation. Thus, the above factors are consolidating the region's position as a dominant force in the global in vitro fertilization (IVF) services market.
ASIA-PACIFIC IS EXPECTED TO HOLD 23.4% OF THE GLOBAL IN VITRO FERTILIZATION (IVF) SERVICES MARKET IN 2024
The rise in infertility cases among both men and women is a significant driver for the IVF market. Factors such as sedentary lifestyles, poor dietary habits, and increased exposure to environmental pollutants contribute to this trend. Common conditions likepolycystic ovary syndrome (PCOS) (https://www.datamintelligence.com/research-report/polycystic-ovary-syndrome-market)and endometriosis further exacerbate infertility rates, leading many couples to seek assisted reproductive technologies like IVF.
Rapid advancements in IVF technologies have significantly improved success rates and treatment effectiveness. Innovations such as controlled ovarian hyperstimulation, embryo culture techniques, and intracytoplasmic sperm injection (ICSI) have enhanced overall outcomes for IVF procedures, making them more appealing to couples facing infertility.
Many governments in the region are introducing supportive policies and funding initiatives aimed at promoting reproductive health services, including IVF. This financial backing helps reduce the costs associated with fertility treatments, making them more accessible to a broader population. India has experienced a notable surge in in vitro fertilization (IVF) services, driven by several interrelated factors. This growth reflects changing societal norms, economic conditions, and increasing awareness surrounding fertility treatments.
Furthermore, key players in the industry are introducing innovative technologies and government initiatives that would drive the global in vitro fertilization (IVF) services market growth. For instance, in January 2025, NewGenIvf Group Limited (NASDAQ: NIVF), a leading fertility services provider in Asia, announced the launch of its innovative lifetime egg freezing service.
This new “one charge, no worries” fertility preservation solution allows women across Asia to make a single payment for lifetime egg freezing, addressing the growing demand for accessible and convenient fertility preservation options. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global in vitro fertilization (IVF) services market.
IN VITRO FERTILIZATION (IVF) SERVICES MARKET MAJOR PLAYERS
The major global players in the in vitro fertilization (IVF) services market include Virtus Health, Genea Pty Limited, Aksigen (https://www.aksigenivf.com/ivf-treatment), Shady Grove Fertility, New Hope Fertility Clinic, Boston IVF, Cyprus IVF Centre, EUVITRO S.L.U., Fertility Centers of Illinois, and Houston Fertility Center, among others.
IN VITRO FERTILIZATION (IVF) SERVICES MARKET - KEY DEVELOPMENTS
• In April 2025, The Wyatt Foundation and The Conceive Fertility Foundation are excited to announce the launch of their 2025 IVF Grant Program. This initiative will provide $15,000 grants to five individuals or couples who require in vitro fertilization (IVF) to grow their families.
• In March 2025, TMRW Life Sciences (https://femtechinsider.com/tmrw-life-sciences-launches-tmrw-vault-a-smart-tank-solution-for-ivf-specimen-management/) announced the launch of TMRW Vault, its latest advancement in the management and storage of frozen IVF specimens such as eggs, embryos, and sperm. The TMRW Vault is a state-of-the-art liquid nitrogen smart tank and digital workstation that combines advanced digital specimen management with the convenience and speed of manual storage access.
• In September 2024, MGM Healthcare (http://thehindu.com/news/cities/chennai/mgm-healthcare-launches-dedicated-centre-for-ivf-services/article68648739.ece) launched its Varam IVF Centre in Chennai, which aims to provide comprehensive and advanced fertility treatments. This initiative is designed to cater to couples facing infertility challenges by combining specialized medical expertise with state-of-the-art technology and a range of ancillary services, all within one facility.
MARKET SCOPE
Metrics Details
CAGR 8.6%
Market Size Available for Years 2022-2033
Estimation Forecast Period 2025-2033
Revenue Units Value (US$ Bn)
Segments Covered Treatment Type Conventional IVF, Intracytoplasmic Sperm Injection (ICSI), Mini IVF, Natural Cycle IVF, Fresh Cycle IVF, Frozen Embryo Transfer (FET), Others
End-User Fertility Clinics, Hospitals, Others
Regions Covered North America, Europe, Asia-Pacific, South America, and Middle East & Africa
The global IVF services market report delivers a detailed analysis with 54 key tables, more than 46 visually impactful figures, and 173 pages of expert insights, providing a complete view of the market landscape.
Table of Contents
180 Pages
- 1. Market Introduction and Scope
- 1.1. Objectives of the Report
- 1.2. Report Coverage & Definitions
- 1.3. Report Scope
- 2. Executive Insights and Key Takeaways
- 2.1. Market Highlights and Strategic Takeaways
- 2.2. Key Trends and Future Projections
- 2.3. Snippet by Treatment Type
- 2.4. Snippet by End User
- 2.5. Snippet by Region
- 3. Dynamics
- 3.1. Impacting Factors
- 3.1.1. Drivers
- 3.1.1.1. Increasing Incidence of Infertility
- 3.1.1.2. Growing Awareness and Acceptance
- 3.1.1.3. Government Initiatives and Insurance Coverage
- 3.1.2. Restraints
- 3.1.2.1. High Costs of IVF Procedures
- 3.1.2.2. Risks and Side Effects
- 3.1.2.3. Shortage of Trained Professionals
- 3.1.3. Opportunity
- 3.1.3.1. Adoption of Advanced Technologies
- 3.1.3.2. Growing Demand for Advanced Procedures
- 3.2. Impact Analysis
- 4. Strategic Insights and Industry Outlook
- 4.1. Market Leaders and Pioneers
- 4.1.1. Emerging Pioneers and Prominent Players
- 4.1.2. Established leaders with the largest-selling Brand
- 4.1.3. Market leaders with established Product
- 4.2. CXO Perspectives
- 4.3. Latest Developments and Breakthroughs
- 4.4. Regulatory and Reimbursement Landscape
- 4.4.1. North America
- 4.4.2. Europe
- 4.4.3. Asia Pacific
- 4.4.4. South America
- 4.4.5. Middle East & Africa
- 4.5. Porter’s Five Forces Analysis
- 4.6. Supply Chain Analysis
- 4.7. Patent Analysis
- 4.8. SWOT Analysis
- 4.9. Unmet Needs and Gaps
- 4.10. Recommended Strategies for Market Entry and Expansion
- 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
- 4.12. Pricing Analysis and Price Dynamics
- 4.13. Key Opinion Leaders
- 5. Global IVF Services Market, By Treatment Type
- 5.1. Introduction
- 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 5.1.2. Market Attractiveness Index, By Treatment Type
- 5.2. Conventional IVF *
- 5.2.1. Introduction
- 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 5.3. Intracytoplasmic Sperm Injection (ICSI)
- 5.4. Mini IVF
- 5.5. Natural Cycle IVF
- 5.6. Fresh Cycle IVF
- 5.7. Frozen Embryo Transfer (FET)
- 5.8. Others
- 6. Global IVF Services Market, By End-User
- 6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 6.1.2. Market Attractiveness Index, By End-User
- 6.2. Fertility Clinics*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.3. Hospitals
- 6.4. Others
- 7. Global IVF Services Market, By Region
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 7.1.2. Market Attractiveness Index, By Region
- 7.2. North America
- 7.2.1. Introduction
- 7.2.2. Key Region-Specific Dynamics
- 7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 7.2.5.1. U.S.
- 7.2.5.2. Canada
- 7.2.5.3. Mexico
- 7.3. Europe
- 7.3.1. Introduction
- 7.3.2. Key Region-Specific Dynamics
- 7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 7.3.5.1. Germany
- 7.3.5.2. U.K.
- 7.3.5.3. France
- 7.3.5.4. Spain
- 7.3.5.5. Italy
- 7.3.5.6. Rest of Europe
- 7.4. South America
- 7.4.1. Introduction
- 7.4.2. Key Region-Specific Dynamics
- 7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 7.4.5.1. Brazil
- 7.4.5.2. Argentina
- 7.4.5.3. Rest of South America
- 7.5. Asia-Pacific
- 7.5.1. Introduction
- 7.5.2. Key Region-Specific Dynamics
- 7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 7.5.5.1. China
- 7.5.5.2. India
- 7.5.5.3. Japan
- 7.5.5.4. South Korea
- 7.5.5.5. Rest of Asia-Pacific
- 7.6. Middle East and Africa
- 7.6.1. Introduction
- 7.6.2. Key Region-Specific Dynamics
- 7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
- 7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8. Competitive Landscape and Market Positioning
- 8.1. Competitive Overview and Key Market Players
- 8.2. Market Share Analysis and Positioning Matrix
- 8.3. Strategic Partnerships, Mergers & Acquisitions
- 8.4. Key Developments in Product Portfolios and Innovations
- 8.5. Company Benchmarking
- 9. Company Profiles
- 9.1. Virtus Health*
- 9.1.1. Company Overview
- 9.1.2. Product Portfolio
- 9.1.2.1. Product Description
- 9.1.2.2. Product Key Performance Indicators (KPIs)
- 9.1.2.3. Historic and Forecasted Product Sales
- 9.1.2.4. Product Sales Volume
- 10. Financial Overview
- 10.1. Company Revenue
- 10.1.1. Geographical Revenue Shares
- 10.1.1.1. Revenue Forecasts
- 10.1.2. Key Developments
- 10.1.2.1. Mergers & Acquisitions
- 10.1.2.2. Key Product Development Activities
- 10.1.2.3. Regulatory Approvals, etc.
- 10.1.3. SWOT Analysis
- 11. Genea Pty Limited.
- 11.1. Aksigen
- 11.2. Shady Grove Fertility
- 11.3. New Hope Fertility Clinic
- 11.4. Boston IVF
- 11.5. Cyprus IVF Centre
- 11.6. EUVITRO S.L.U.
- 11.7. Fertility Centers of Illinois
- 11.8. Houston Fertility Center (*LIST NOT EXHAUSTIVE)
- 12. Assumptions and Research Methodology
- 12.1. Data Collection Methods
- 12.2. Data Triangulation
- 12.3. Forecasting Techniques
- 12.4. Data Verification and Validation
- 13. Appendix
- 13.1. About Us and Services
- 13.2. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
